Sector Gamma AS raised its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 36.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 10,883 shares of the company’s stock after buying an additional 2,883 shares during the period. Sector Gamma AS’s holdings in HCA Healthcare were worth $4,638,000 at the end of the most recent quarter.
A number of other institutional investors also recently bought and sold shares of the stock. Park Place Capital Corp increased its holdings in HCA Healthcare by 2,336.0% in the 2nd quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock worth $474,000 after acquiring an additional 1,168 shares in the last quarter. Cerity Partners LLC grew its stake in HCA Healthcare by 13.1% during the third quarter. Cerity Partners LLC now owns 43,920 shares of the company’s stock valued at $18,719,000 after acquiring an additional 5,092 shares in the last quarter. Swiss National Bank boosted its holdings in shares of HCA Healthcare by 4.3% during the 2nd quarter. Swiss National Bank now owns 558,900 shares of the company’s stock valued at $214,115,000 after purchasing an additional 23,100 shares during the last quarter. Cherokee Insurance Co purchased a new stake in shares of HCA Healthcare in the second quarter worth about $3,869,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al grew its holdings in HCA Healthcare by 4.2% during the 3rd quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 297,300 shares of the company’s stock valued at $126,709,000 after buying an additional 11,900 shares in the last quarter. 62.73% of the stock is owned by institutional investors.
HCA Healthcare Stock Performance
HCA Healthcare stock opened at $470.52 on Friday. The company has a 50 day moving average price of $480.37 and a 200-day moving average price of $433.92. The company has a market capitalization of $107.37 billion, a PE ratio of 18.19, a P/E/G ratio of 1.30 and a beta of 1.36. HCA Healthcare, Inc. has a fifty-two week low of $295.00 and a fifty-two week high of $520.00.
Wall Street Analyst Weigh In
A number of research firms have recently commented on HCA. Raymond James Financial set a $525.00 target price on HCA Healthcare in a research report on Monday, October 27th. Jefferies Financial Group boosted their target price on HCA Healthcare from $525.00 to $535.00 and gave the company a “buy” rating in a research report on Thursday. KeyCorp restated an “overweight” rating and issued a $500.00 target price on shares of HCA Healthcare in a report on Thursday. Sanford C. Bernstein reissued a “market perform” rating and issued a $503.00 price objective on shares of HCA Healthcare in a research report on Tuesday, January 6th. Finally, TD Cowen reiterated a “buy” rating on shares of HCA Healthcare in a report on Monday, October 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $488.75.
Insider Activity
In other news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the transaction, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.30% of the company’s stock.
HCA Healthcare Company Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Read More
- Five stocks we like better than HCA Healthcare
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- The $100 Trillion AI Story No One Is Telling You
- NEW LAW: Congress Approves Setup For Digital Dollar?
- A U.S. “birthright” claim worth trillions – activated quietly
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
